Vnitr Lek 1994, 40(4):219-222

[Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study].

V Bugán, B Renker, P Brunclík, D Baraniková, E Augustín
Interné oddelenia B, NsP Zilina.

The authors evaluated in a five-year retrospective study the success of pharmacological and electric cardioversion in general in 353 patients with atrial fibrillation and in 117 patients with atrial flutter. The success of electric cardioversion in the group with fibrillation arrhythmia was 72%, in the group with atrial flutter 92%. The success of pharmacological cardioversion in the group with fibrillation arrhythmia was 96.2%, in the group with atrial flutter 79.8%. In pharmacological cardioversion in both groups the combination quinidine-isoptin was best.

Keywords: Anti-Arrhythmia Agents, therapeutic use, ; Atrial Fibrillation, therapy, ; Atrial Flutter, therapy, ; Electric Countershock; Humans; Middle Aged; Retrospective Studies

Published: April 1, 1994  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bugán V, Renker B, Brunclík P, Baraniková D, Augustín E. [Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study]. Vnitr Lek. 1994;40(4):219-222.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)

    • Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.